P- Reviewer: Rabinowitz SS S- Editor: Wen LL L- Editor: A E- Editor: Liu XM
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15745
Revised: May 5, 2014
Accepted: May 19, 2014
Published online: November 14, 2014
AIM: To evaluate the prevalence of John Cunningham virus (JC virus) in a small cohort of patients with colon cancer and to assess its presence in hepatic metastasis.
METHODS: Nineteen consecutive patients with histologically diagnosed colon cancer were included in our study, together with ten subjects affected by histologically and serologically diagnosed hepatitis C virus infection. In the patients included in the colon cancer group, JC virus was searched for in the surgical specimen; in the control group, JC virus was searched for in the hepatic biopsy. The difference in the prevalence of JC virus in the hepatic biopsy between the two groups was assessed through the χ2 test.
RESULTS: Four out of 19 patients with colon cancer had a positive polymerase chain reaction (PCR) test for JC virus, and four had liver metastasis. Among the patients with liver metastasis, three out of four had a positive PCR test for JC virus in the surgical specimen and in the liver biopsy; the only patient with liver metastasis with a negative test for JC virus also presented a negative test for JC virus in the surgical specimen. In the control group of patients with hepatitis C infection, none of the ten patients presented JC virus infection in the hepatic biopsy. The difference between the two groups regarding JC virus infection was statistically significant (χ2 = 9.55, P = 0.002).
CONCLUSION: JC virus may play a broader role than previously thought, and may be mechanistically involved in the late stages of these tumors.
Core tip: This is the first case-control study, to our knowledge, assessing, although with a small sample size, the potential metastatic spread of John Cunningham virus associated with colon cancer.
Citation: Sinagra E, Raimondo D, Gallo E, Stella M, Cottone M, Orlando A, Rossi F, Orlando E, Messina M, Tomasello G, Lo Monte AI, La Rocca E, Rizzo AG. Could JC virus provoke metastasis in colon cancer? World J Gastroenterol 2014; 20(42): 15745-15749
Colorectal cancer (CRC) is the third most frequent malignancy, and constitutes the second leading cause of cancer mortality among both men and women in the United States. Mortality in CRC is usually caused by metastatic disease. Even if increasing efforts to the diagnosis of CRC at an early stage with screening programs, more than 25% of patients are still diagnosed with metastatic disease, and a further 25% develop metastases. Up to now, the molecular mechanisms underlying the development of metastasis are not fully understood. Actually, infectious diseases are acquiring relevance because they are thought as leading pathogenic elements in human cancer: in fact all about twenty percent of human cancers are associated with infectious agents, particularly in the gastrointestinal tract, but this is not a mainstream oncologic research area. It has been thought that the development of several types of human cancers could be triggered by exposure to different infectious agents, such as human papilloma virus (HPV) infection associated with cervical carcinoma, hepatitis B virus associated with liver carcinoma, Epstein-Barr virus associated with Burkitt lymphomas, HTVL-1 associated with Adult T-cell Leukemia/Lymphoma, or Helicobacter pylori associated with gastric carcinoma; more recently a human retrovirus, XMRV, has been associated with sporadic prostate cancer[9-11]. In addition, an association has been reported between the development of lower gastrointestinal tract neoplasias and infectious agents, e.g., between CRC and John Cunningham virus (JC virus) infection.
JC virus, a member of the polyomaviridae family, ubiquitously infects humans, 70% to 80% of the adult population having JC virus-specific antibodies[12,13]. Several studies demonstrated that JC virus infection takes place during early childhood and remains subclinical. After primary infection, JC virus can be found in the kidneys, B lymphocytes, and gut mucosa.
However, under conditions of severe immunosuppression, the virus could become reactivated and induce the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML). In addition, there is an increasing evidence that JC virus may be associated with several human neoplasias. In fact, JC virus genomic sequences and oncogenic T-antigen (T-Ag) expression have been reported in a variety of human malignancies, including brain tumors[15,16] CRC[17-20], gastric cancer, and esophageal cancer.
JC virus has been reported to be associated with CRC and could contribute to the cancer phenotype by several mechanisms. Among JC virus proteins, two in particular, large T-antigen and agnoprotein, could interfere with cell cycle control and genomic instability mechanisms, but further viral proteins could also contribute to cell transformation. Some viral DNA sequences are found in carcinoma lesions, but less frequently in adenomas, and not in the normal tissue. These findings suggest that viral DNA integration in the host cell genome might result in chromosomal damage and malignant transformation. However, to date its role in provoking metastasis has not been demonstrated, though it has been hypothesized that JC virus T-Ag could mediate metastasis in CRC cells through increased migration and invasion.
The aim of this study is to evaluate the prevalence of JC virus in a small cohort of patient with colon cancer and to assess its presence in hepatic metastasis, comparing it with a cohort of patients with liver disease but without colon cancer.
Nineteen consecutive patients (47.4% male, 52.6% female) with histologically diagnosed colon cancer, followed between January 2012 and October 2012 at our hospital, were included in the study, together with ten subjects, employed as a control group of individuals in the same geographic areas, affected by histologically and serologically diagnosed hepatitis C virus infection. This cohort of control subject was chosen to assess the prevalence of JC virus in the livers of patients without known primary colorectal cancer.
Among patients from the colon cancer group, JC virus was searched for in the surgical specimen (primary colon cancer tissue and liver metastasis tissue); in the control group, JC virus was searched for in the hepatic biopsy. Liver biopsies were all standard percutaneous samples, and the threshold of adequacy for histological assessment was the presence of more than five portal tracts.
The difference in the prevalence of JC virus in the hepatic biopsy between the two groups was assessed through the χ2 test.
Paraffin-embedded tissues were sectioned at 10 microns and five sections were cut with a standard microtome and transferred into a 1.5 mL microtube.
To prevent cross-contamination between the samples, the microtome blade was washed with xylene and ethanol after sectioning of each block.
Genomic DNA was extracted from paraffin embedded tissue section using the ZR Genomic DNA-Tissue Miniprep (Zymo Research, United States), according to the manufacturer’s recommendations.
Extreme caution was taken to perform all preparatory polymerase chain reaction (PCR) steps, including DNA extraction in a separate room isolated from any post-PCR samples to prevent contamination.
All the DNA samples were amplified using beta-globin primers (fragment of 175 bp) to confirm their integrity.
For the detection of JC virus gene sequences, polymerase chain reaction amplifications were performed using gene-specific primers for T-antigen.
For JC virus T-antigen, T1 and T2 (nucleotides 3049-3069 of the Mad-1 strain, 5’ TGGCCTGTAAAGTTCTAGGCA 3’ and 3229-3207, 5’ GCAGAGTCAAGGGATTTACCTTC 3’ respectively) which amplify sequences in the NH2-terminal region of the JC virus T-antigen, were used for the first PCR, whereas T1 and T3 (nucleotides 3193-3171, 5’ AGCAACCTTGATTGCTTAAGAGA 3’) were used for the second PCR (110 bp).
PCR reaction mixture contained 0.5 U Taq polymerase, 1 × PCR Buffer (50 mmol/L KCl and 10 nmol/L MgCl2, 10 pmol of each dNTPs, 1.5 mmol/L MgCl2, 10 pmol of each primers and 100-200 ng of extracted DNA.
PCR conditions were denatured at 95 °C for 10 min, followed by 30 cycles of denaturation at 95 °C for 15 s , annealing at 55 °C for 30 s and extension at 72 °C for 30 s followed by 7 min final extension at 72 °C.
Nested PCR was carried out as the first PCR cycles, using 1% (volume) of the first PCR product with internal primers.
The PCR amplification products were run on 2% agarose gel and stained with ethidium bromide and visualized under ultraviolet light.
Clinical and demographical data of the study population are summarized in Table 1.
|Age (median, range), yr||70 (59-87)|
|Location of the colorectal cancer (n)||Caecum and ascending colon: 12/19|
|Transverse colon: 1/19|
|Descending colon: 2/19|
|Staging according to Dukes’ Classification (n)||A: 0/19|
|Mucinous component (n)||5:19|
|Signet ring component (n)||5:19|
|Presence of tumor infiltrating lymphocytes (n)||12:19|
|Perineural invasion (n)||10:19|
|Microvascular invasion (n)||10:19|
|JC virus positivity in the colonic specimen (n)||4:19|
|Liver metastasis (n)||4:19|
|JC virus positivity in the hepatic specimen (n)||3:19|
Four out of 19 patients (21.05%) with colon cancer had a positive PCR test for JC virus, and four (21.05%) had liver metastasis. Among the four patients with liver metastasis, three out of 4 (75%) had a positive PCR test for JC virus both in the surgical specimen and in the liver specimen; the only patient with liver metastasis with a negative test for JC virus also presented a negative test for JC virus in the primary tumor.
In the control group of patients with hepatitis C infection, none of the ten patients (0%) presented JC virus infection in the hepatic biopsy.
The difference between the two groups regarding JC virus infection was statistically significant (χ2 = 9.55, P = 0.002).
JC virus DNA sequences and proteins have been found in a wide range of human neoplasias of glial and non-glial origin, as gliomas, ependymomas and medulloblastomas, as well as in several non-neural clinical specimens of gastrointestinal tumors, such as CRC, suggesting that they could infect a broad range of cell types. However, the role of JC virus in such neoplasias is poorly understood.
Even if several studies have evaluated the role of the presence of JC virus DNA in colonic tissue using PCR, more recently Burnett-Hartman and coworkers reviewed five studies examining colorectal neoplastic tissue detecting JC virus DNA in colorectal neoplasias at varying frequencies, finding from 26% to 89% of carcinomas positive for JC virus.
A very important challenge is to establish whether the presence of JC virus presents any difference between tumors of different grades and its normal surrounding mucosa. Few studies have been performed in this context.
Two studies evaluated colorectal adenomatous tissue from separate patients with adenomas and normal colorectal tissues from controls. The first study reported a JC virus infection in 61% of cancerous tissue, 60% of adenomatous tissue and 30% of normal tissue samples from controls, showing a OR = 6.2 (95%CI: 2.4-16.6) comparing neoplastic tissue to normal tissue. This study showed that JC virus viral copy numbers were statistically significantly higher in neoplastic colorectal tissue with regard to normal colorectal tissue. The second study presented lower rates of detection for JC virus, finding 26% of cancerous colorectal tissue, 5% of adenomas and 0% of normal tissue positive for JC virus.
Furthermore, in the study performed by Link and coworkers, some phenotypic changes were demonstrated that were associated with marked alterations in the expression of a large number of genes of JC virus. These results are in line with a previous study by Nerurkar and colleagues in which the authors analyzed gene expression alterations following transfection of a full-length JC virus plasmid into glial cells. Indeed, the study of Link and coworkers suggests a novel role for JC virus T-Ag in human CRC. The authors demonstrated that transfection of JC virus early transcripts into cancer cells could increases migration and invasion through up-regulation of metastasis-associated genes.
Our study presents some limitations, like the retrospective design, the small number of patients with liver metastasis and the absence of detection of JC virus in the normal mucosa surrounding the colorectal cancer, as well as the absence of mention of the level of viral expression in the analyzed tissue. However, the primary aim of our study was simply to assess the presence of JC virus in the hepatic metastasis of colorectal cancer, comparing it with a cohort of patients with liver disease but without colon cancer. Furthermore, our points of strength are the presence of a control group and the finding of a prevalence of JC virus, in colon cancer, which has largely been overlooked in the scientific literature, with the finding of the scientific literature, with the exception of the study performed by Link and co-workers.
Based on this data, we propose that JC virus T-Ag may play a broader role than previously thought, and may be mechanistically involved in the late stages of these tumors.
Forthcomings prospective case-control studies, with a larger number of patients in both the arms and targeted to evaluate the difference in the level of expression of JC virus in the primary tumoral colonic tissue and in the normal surrounding colonic mucosa, as well as to study migration and invasion, could clarify the true prevalence of JC virus in colon cancer and in liver metastasis, making it possible to find a true “mechanical” role of JC virus in the late stages of CRC.
Infectious diseases are acquiring relevance as important pathogenic elements in human cancer, since almost one fifth of human cancers are associated with infectious agents, particularly in the gastrointestinal tract. An association has recently been reported between colorectal cancer and John Cunningham virus (JC virus) infection.
Up to date, the role of JC virus in provoking metastasis has not been demonstrated, though it has been hypothesized that JC virus T-Ag may mediate metastasis in colorectal cancer (CRC) cells through increased migration and invasion.
Recent reports have demonstrated that transfection of JC virus early transcripts into cancer cells could increases migration and invasion through up-regulation of metastasis-associated genes. Increased expression of phosphorylated AKT and ERK1/2 and the reversible effect of PI3K/AKT and MAPK pathway inhibitors imply, at least in part, the involvement of PI3K/AKT and MAPK pathways. Detection of JC virus T-Ag expression in primary CRCs and their metastases suggests a novel role for JC virus T-Ag in metastasis during the late stages of CRC.
This is the first case-control study, to our knowledge, assessing, although with a small sample size, the potential metastatic spreading of JC-virus associated colon cancer.
JC virus, a member of the polyomaviridae family, ubiquitously infects humans, 70% to 80% of the adult population having JC virus-specific antibodies. Epidemiological studies have demonstrated that JC virus infection takes place during early childhood and usually remains subclinical. JC virus has been associated with colorectal cancer and might contribute to the cancer phenotype by several mechanisms. Among JC virus proteins, two in particular, large T-antigen and agnoprotein, can interfere with cell cycle control and genomic instability mechanisms, but other viral proteins might also contribute to cell transformation.
Authors are presenting preliminary data on an interesting association, JC virus and colon cancer. Their results of 4/19 patients with colorectal cancer having polymerase chain reaction evidence of JC virus infection are supportive of this association and are therefore worthy of publication.
|1.||Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249. [PubMed] [DOI]|
|2.||Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895-904. [PubMed] [DOI]|
|3.||Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-3044. [PubMed] [DOI]|
|4.||zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350. [PubMed] [DOI]|
|5.||Blumberg BS, London WT. Hepatitis B virus and the prevention of primary cancer of the liver. J Natl Cancer Inst. 1985;74:267-273. [PubMed]|
|7.||Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270-280. [PubMed]|
|8.||Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2008;17:2970-2979. [PubMed] [DOI]|
|9.||Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006;2:e25. [PubMed]|
|10.||Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA. 2007;104:1655-1660. [PubMed]|
|11.||Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, Aepfelbacher M, Schlomm T. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol. 2008;43:277-283. [PubMed] [DOI]|
|12.||Taguchi F, Kajioka J, Miyamura T. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol. 1982;26:1057-1064. [PubMed]|
|13.||Stolt A, Sasnauskas K, Koskela P, Lehtinen M, Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol. 2003;84:1499-1504. [PubMed] [DOI]|
|14.||Gordon J, Khalili K. The human polyomavirus, JCV, and neurological diseases (review). Int J Mol Med. 1998;1:647-655. [PubMed]|
|15.||Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis JN, Katsetos CD, Croul S, Khalili K. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res. 2001;61:4287-4293. [PubMed]|
|16.||Del Valle L, Gordon J, Enam S, Delbue S, Croul S, Abraham S, Radhakrishnan S, Assimakopoulou M, Katsetos CD, Khalili K. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst. 2002;94:267-273. [PubMed] [DOI]|
|17.||Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA. 1999;96:7484-7489. [PubMed] [DOI]|
|18.||Ricciardiello L, Chang DK, Laghi L, Goel A, Chang CL, Boland CR. Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol. 2001;75:1996-2001. [PubMed] [DOI]|
|19.||Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, Palazzo JP, Khalili K. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res. 2002;62:7093-7101. [PubMed]|
|20.||Theodoropoulos G, Panoussopoulos D, Papaconstantinou I, Gazouli M, Perdiki M, Bramis J, Lazaris ACh. Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum. 2005;48:86-91. [PubMed] [DOI]|
|21.||Shin SK, Li MS, Fuerst F, Hotchkiss E, Meyer R, Kim IT, Goel A, Boland CR. Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. Cancer. 2006;107:481-488. [PubMed] [DOI]|
|22.||Del Valle L, White MK, Enam S, Piña Oviedo S, Bromer MQ, Thomas RM, Parkman HP, Khalili K. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer. 2005;103:516-527. [PubMed]|
|23.||Coelho TR, Almeida L, Lazo PA. JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? Virol J. 2010;7:42. [PubMed] [DOI]|
|24.||Link A, Shin SK, Nagasaka T, Balaguer F, Koi M, Jung B, Boland CR, Goel A. JC virus mediates invasion and migration in colorectal metastasis. PLoS One. 2009;4:e8146. [PubMed] [DOI]|
|25.||Zheng H, Murai Y, Hong M, Nakanishi Y, Nomoto K, Masuda S, Tsuneyama K, Takano Y. JC [corrected] virus detection in human tissue specimens. J Clin Pathol. 2007;60:787-793. [PubMed]|
|26.||Hori R, Murai Y, Tsuneyama K, Abdel-Aziz HO, Nomoto K, Takahashi H, Cheng CM, Kuchina T, Harman BV, Takano Y. Detection of JC virus DNA sequences in colorectal cancers in Japan. Virchows Arch. 2005;447:723-730. [PubMed]|
|27.||Lin PY, Fung CY, Chang FP, Huang WS, Chen WC, Wang JY, Chang D. Prevalence and genotype identification of human JC virus in colon cancer in Taiwan. J Med Virol. 2008;80:1828-1834. [PubMed] [DOI]|
|28.||Verma S, Ziegler K, Ananthula P, Co JK, Frisque RJ, Yanagihara R, Nerurkar VR. JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets. Virology. 2006;345:457-467. [PubMed]|